Introduction
============

Visual loss in cryptococcal meningitis may occur from chronically elevated intracranial pressure, adhesive arachnoiditis, or direct invasion of the visual sensory pathway by the organism ([@b5-co-2-637]; [@b1-co-2-637]; [@b3-co-2-637]; [@b4-co-2-637]; [@b2-co-2-637]). Medical therapy with antifungal agents and surgical treatment, directed towards lowering the increased intracranial pressure, have met with variable success. There are, however, several reports of successful treatment of papilledema and visual loss by surgical methods, even in the presence of direct invasion of the brain tissues by the organism ([@b2-co-2-637]; [@b3-co-2-637]). Our patient similarly experienced a remarkable improvement in vision and papilledema after optic nerve sheath fenestration despite the presence of cryptococcus in the optic nerve sheath.

Case report
===========

A 25-year-old patient with acquired immunodeficiency syndrome (AIDS) developed headaches, seizures, altered mental status, and visual loss. Lumbar puncture showed markedly increased opening cerebral spinal fluid (CSF) pressure; cryptococcal organisms were identified by India ink preparation and in culture. Despite medical treatment with intravenous amphotericin B and oral fluconazole for cryptococcal meningitis, visual loss progressed to 20/200 OD and light perception OS within several weeks. Ophthalmoscopy revealed bilateral optic nerve edema ([Figure 1A](#f1-co-2-637){ref-type="fig"}). Magnetic resonance imaging showed leptomeningeal and optic nerve enhancement without hydrocephalus ([Figure 2](#f2-co-2-637){ref-type="fig"}). Because of progressive severe visual loss despite medical management, and in light of increased intracranial pressure and papilledema, the patient was recommended to have bilateral optic nerve sheath fenestration.

Histopathologic evaluation of the (bilateral) optic nerve sheath fenestration specimen revealed infiltration of the meninges by yeast-form organisms, consistent with cryptococci ([Figure 3](#f3-co-2-637){ref-type="fig"}). Two weeks after surgery, the patient's optic nerve edema resolved ([Figure 1B](#f1-co-2-637){ref-type="fig"}) and vision improved to 20/80 OD and hand motions OS.

Discussion
==========

*Cryptococcus neoformans* is the most common life-threatening fungal pathogen that infects patients with AIDS ([@b2-co-2-637]). Cryptococcal infection typically manifests as meningitis with secondary ocular involvement. Abnormal ocular findings are seen in about 40% of the patients, with papilledema being the most common presenting sign ([@b4-co-2-637]).

The diagnosis of cryptococcal meningitis is suggested by a constellation of clinical and radiographic findings and is supported by a diagnostic lumbar puncture. High opening pressure and the presence of cryptococcal antigen and organisms in cerebrospinal fluid of affected patients are diagnostic of cryptococcal meningitis ([@b1-co-2-637]; [@b3-co-2-637]; [@b4-co-2-637]; [@b2-co-2-637]).

When the tissue is available for histopathologic diagnosis, cryptococcal organisms may be identified in meningeal sheath, subarachnoid space, and, occasionally, within the brain parenchyma. This budding yeast has thick gelatinous capsule that stain with periodic acid-Schiff, silver, mucicarmine, and acid mucopolysaccharide stains. Little reactive inflammation is seen in surrounding tissues ([@b1-co-2-637]; [@b3-co-2-637]; [@b2-co-2-637]).

Untreated, cryptococcal meningitis is almost always a fatal disease. Medical treatment with intravenous amphotericin B and oral fluconazole has a guarded prognosis, and permanent neurologic and ophthalmologic sequelae are common ([@b3-co-2-637]). Another treatment goal is directed toward lowering increased intracranial pressure, which may contribute to optic atrophy and visual loss. Repeated lumbar punctures, CSF diverting procedures, and optic nerve sheath fenestration have met with variable success ([@b1-co-2-637]; [@b3-co-2-637]; [@b2-co-2-637]; [@b6-co-2-637]). Interestingly, involvement of the brain by cryptococcal organisms has been demonstrated in several patients who benefited from a shunting procedure ([@b3-co-2-637]). [@b2-co-2-637] similarly reported visual improvement in two patients with cryptococcal meningitis, treated with optic nerve sheath fenestration. Cryptococcal organisms were present in dural sheath specimens of both patients despite ongoing therapy with antifungal medication ([@b2-co-2-637]). Our patient had analogous presentation of decreased vision, optic nerve head edema, and increased intracranial pressure. Partial visual rehabilitation was achieved following optic nerve sheath fenestration despite histopathologically documented optic nerve sheath involvement by fungi.

It appears that no single formula can be applied in management of cryptococcal meningitis. Medical treatment of the infection should be aggressively pursued. When high intracranial pressure appears to contribute to visual loss, optic nerve sheath fenestration may offer a treatment alternative to protect the optic nerves from the effects of chronic papilledema.
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![Fundus photograph of the right eye (**A**) reveals marked optic nerve head edema. Same eye, two weeks after optic nerve sheath fenestration with resolution of optic nerve head edema (**B**).](co-2-637f1){#f1-co-2-637}

![T1 weighted, axial MRI of the brain with contrast reveals diffuse leptomeningeal enhancement (**A**). T2 weighted, coronal MRI of the brain reveals thickening of the optic nerve-meningeal complex (↑) and increased CSF signal in subarachnoid space (**B**).\
**Abbreviations:** CSF, cerebral spinal fluid; MRI, magnetic resonance image.](co-2-637f2){#f2-co-2-637}

![Budding yeast organisms stain with Gomori methenamine silver stain (**A**) (GMS stain; high power). The capsules of cryptococci stain with mucicarmine stain (**B**) (Mucicarmine stain; high power).](co-2-637f3){#f3-co-2-637}
